DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Chesterfield, MO

8 verified pulmonary disease doctors in Chesterfield.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Missouri Board of Registration for the Healing Arts

Dr. Steven Brown, MD

Pulmonary Disease

21 yrs NPPES
NPI 1619960655
133 BRIGHTHURST DR, Chesterfield, MO 63005(414) 581-5864
NPPES public registry
CMS Open Payments· $16.57 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$16.57

Total received

1

Transactions

1

Paying companies

Top paying companies

IDORSIA PHARMACEUTICALS US INC$16.57

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Steven Brown do not imply any wrongdoing. Many are meals, education, or research support.

Dr. John Wood, MD

Pulmonary Disease

20 yrs NPPES
NPI 1538182811
224 S WOODS MILL RD, SUITE 500 SOUTH, Chesterfield, MO 63017(317) 878-6260
NPPES public registry
CMS Open Payments· $640.78 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$640.78

Total received

31

Transactions

16

Paying companies

Top paying companies

Lilly USA, LLC$127.55
AstraZeneca Pharmaceuticals LP$62.57
Kiniksa Pharmaceuticals, Ltd.$59.62
Novo Nordisk Inc$59.18
GlaxoSmithKline, LLC.$55.37
Mylan Specialty L.P.$47.92

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to John Wood do not imply any wrongdoing. Many are meals, education, or research support.

Dr. John Best, MD

Pulmonary Disease

20 yrs NPPES
NPI 1053429977
222 S WOODS MILL RD, SUITE 310 NORTH, Chesterfield, MO 63017(314) 576-6700
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Neil Ettinger, MD

Pulmonary Disease

20 yrs NPPES
NPI 1619086451
222 S WOODS MILL RD, SUITE 310N, Chesterfield, MO 63017(314) 576-6700
NPPES public registry
CMS Open Payments· $375,889 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$375,889

Total received

231

Transactions

29

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$103,813
United Therapeutics Corporation$94,693
Roche Products Limited$72,027
GlaxoSmithKline, LLC.$28,336
Genentech, Inc.$19,464
E.R. Squibb & Sons, L.L.C.$16,818

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Neil Ettinger do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Adnan Habib, MD

Pulmonary Disease

20 yrs NPPES
NPI 1730298381
15740 S OUTER 40 RD, Chesterfield, MO 63017(606) 329-1185
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Rhody Eisenstein, MD

Pulmonary Disease

19 yrs NPPES
NPI 1063558948
232 S WOODS MILL RD, Chesterfield, MO 63017(314) 205-6030
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Bobby Shah, MD

Pulmonary Disease

19 yrs NPPES
NPI 1538340930
222 S WOODS MILL RD, Chesterfield, MO 63017(314) 576-6700
NPPES public registry
CMS Open Payments· $32,470 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$32,470

Total received

206

Transactions

24

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$27,188
Mylan Specialty L.P.$2,954
AstraZeneca Pharmaceuticals LP$352.47
Regeneron Healthcare Solutions, Inc.$312.67
Genzyme Corporation$229.75
Boehringer Ingelheim Pharmaceuticals, Inc.$225.74

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Bobby Shah do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kristen Fisher, MD

Pulmonary Disease

16 yrs NPPES
NPI 1316268600
222 S WOODS MILL RD STE 310N, Chesterfield, MO 63017(314) 682-3630
NPPES public registry
CMS Open Payments· $3,048 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,048

Total received

144

Transactions

24

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$474.75
AstraZeneca Pharmaceuticals LP$388.81
Regeneron Healthcare Solutions, Inc.$275.25
Boehringer Ingelheim Pharmaceuticals, Inc.$267.96
Genzyme Corporation$200.95
Insmed, Inc.$169.16

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kristen Fisher do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Chesterfield, MO — Verified | DoctorsProof | DoctorsProof